256 Participants Needed

Family Support Program for Autism

JL
NM
NM
ML
Overseen ByMei L Elansary, MD
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: Boston Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

A randomized controlled trial will be conducted to determine the effects of an adapted family-centered autism transition intervention called Transitioning Together/Juntos en la Transición on meaningful outcomes for families. The study will occur in a safety net hospital setting. The adapted version of this multi-family group psychoeducation intervention is delivered across one individual family joining session and four 2.5 hour multi-family group sessions. The parent and youth groups are held in separately, at the same time.

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications.

What data supports the effectiveness of the treatment Transitioning Together (TT) / Juntos en la Transicion (JET) for autism?

Research shows that the Transitioning Together program helps reduce family stress and improve social interactions for adolescents with autism. Parents also reported feeling less depressed and better at solving problems after participating in the program.12345

Is the Family Support Program for Autism, also known as Transitioning Together, safe for participants?

The Transitioning Together program has been implemented in various settings and received positive feedback from families, with no reported safety concerns. Participants have reported improvements in family distress and social functioning, suggesting it is generally safe for use.24567

How is the Transitioning Together treatment unique for autism?

Transitioning Together is unique because it is a multi-family group psychoeducation program specifically designed to reduce family stress and improve social interactions for adolescents with autism and their families. Unlike other treatments, it focuses on the family environment and provides a platform for families to interact and support each other during the transition to adulthood.12489

Research Team

JL

Jocelyn L Kuhn, PhD

Principal Investigator

Emory School of Medicine

ME

Mei L Elansary, MD, MD

Principal Investigator

Boston Medical Center, Pediatrics

Eligibility Criteria

This trial is for families with a youth aged 14-21 diagnosed with autism, who have visited BMC since 2015 and are in high school or specialized schooling. Parents must be comfortable with English/Spanish and live with the youth.

Inclusion Criteria

For youth: Currently live at home with a parent/legal guardian
I am a parent and I am at least 21 years old.
My parent or legal guardian meets the required criteria.
See 6 more

Exclusion Criteria

The autistic youth currently resides independently, in supported housing, or with a foster family or other Department of Children and Families (DCF) placement
Both my child and I agree to participate in the study.
My family's primary language at home is neither English nor Spanish.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive the Transitioning Together intervention, consisting of one individual family joining session and four 2.5-hour multi-family group sessions

5 weeks
5 sessions (in-person or virtual)

Follow-up

Participants are monitored for changes in quality of life, transition readiness, and other outcomes

3-12 months

Treatment Details

Interventions

  • Transitioning Together (TT) / Juntos en la Transicion (JET)
  • Usual autism transition care
Trial Overview The study tests 'Transitioning Together/Juntos en la Transición,' an intervention involving one family session and four group sessions to improve outcomes for families dealing with autism transitions.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Transitioning TogetherExperimental Treatment1 Intervention
Participants in this arm will receive the Transitioning Together intervention in English or Spanish either at BMC, at BMC's Supporting Parents \& Resilient Kids (SPARK) Center or on BMC Zoom.
Group II: Usual CareActive Control1 Intervention
Participants in this arm will receive a referral to usual transition-related care through the BMC Developmental and Behavioral Pediatrics (DBP) clinic/the BMC Autism Program.

Transitioning Together (TT) / Juntos en la Transicion (JET) is already approved in United States for the following indications:

🇺🇸
Approved in United States as Transitioning Together for:
  • Supporting families of adolescents on the autism spectrum in transitioning to adulthood

Find a Clinic Near You

Who Is Running the Clinical Trial?

Boston Medical Center

Lead Sponsor

Trials
410
Recruited
890,000+

Deborah Munroe Noonan Memorial Research Fund

Collaborator

Trials
6
Recruited
390+

Findings from Research

The 'Transitioning Together' psychoeducation program was developed to help reduce family stress and improve the quality of life for families with adolescents who have autism, highlighting its potential efficacy in supporting these families.
A case study demonstrated that the program effectively reduced family stress and enhanced the overall family environment, suggesting positive outcomes for families involved in the program.
The family context of autism spectrum disorders: influence on the behavioral phenotype and quality of life.Smith, LE., Greenberg, JS., Mailick, MR.[2021]
The BOOST-A™ program is an online interactive transition planning tool designed specifically for adolescents on the autism spectrum, aiming to enhance their self-determination and support successful transitions from high school to further education or employment.
The trial will assess the program's effectiveness by comparing outcomes in self-determination and other related factors between participants using BOOST-A™ and those receiving regular transition planning practices, with data collected at baseline and after 12 months.
Evaluation of the effectiveness of an online transition planning program for adolescents on the autism spectrum: trial protocol.Hatfield, M., Falkmer, M., Falkmer, T., et al.[2020]
The transition from pediatric to adult care for youth with autism spectrum disorders is often poorly coordinated, which can negatively impact their long-term health outcomes.
A survey study revealed that both pediatric and adult healthcare providers face challenges in implementing best practices for this transition, indicating a need for improved medical coordination and additional training resources.
Transitioning youth with autism spectrum disorders and other special health care needs into adult primary care: A provider survey.Ames, JL., Massolo, ML., Davignon, MN., et al.[2021]

References

The family context of autism spectrum disorders: influence on the behavioral phenotype and quality of life. [2021]
Evaluation of the effectiveness of an online transition planning program for adolescents on the autism spectrum: trial protocol. [2020]
Transitioning youth with autism spectrum disorders and other special health care needs into adult primary care: A provider survey. [2021]
Transitioning Together: A Multi-family Group Psychoeducation Program for Adolescents with ASD and Their Parents. [2019]
Process Evaluation of the BOOST-A™ Transition Planning Program for Adolescents on the Autism Spectrum: A Strengths-Based Approach. [2019]
Implementation of a multi-family autism transition program in the high school setting. [2022]
7.Russia (Federation)pubmed.ncbi.nlm.nih.gov
Disrupted Care Continuity: Testing Associations between Social Networks and Transition Success for Children with Autism. [2022]
Effectiveness of the BOOST-A™ online transition planning program for adolescents on the autism spectrum: a quasi-randomized controlled trial. [2022]
"Don't Promise Something You can't Deliver:" Caregivers' Advice for Improving Services to Adolescents and Young Adults with Autism. [2023]